Adrenocortical carcinoma (ACC) accounts for a minority of all malignant tumors in adults.
Surgery remains the most important therapeutic option for non-metastatic ACC. Whether a …

Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing
tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with …

Adrenocortical carcinoma (ACC) is a rare malignancy that is frequently asymptomatic at
presentation, yet has a high rate of metastatic disease at the time of diagnosis. Prognosis is …

Context Although mitotane is the only approved drug for the treatment of adrenocortical
carcinoma (ACC), data on monotherapy in advanced disease are still scarce. Objective To …

Background Identifying cognitive impairment early enough could support timely intervention
that may hinder or delay the trajectory of cognitive impairment, thus increasing the chances …

Background and Purpose—This study aimed to develop and validate a nomogram for
predicting the risk of stroke recurrence among young adults after ischemic stroke. Methods …

Objective Adrenocortical carcinoma (ACC) has an aggressive but variable clinical course.
Prognostic stratification based on the European Network for the Study of Adrenal Tumours …

Purpose To propose a novel histopathological classification system for microvascular
invasion (MVI) and to establish nomograms to predict postoperative survival and early tumor …

Background Collagen fibers play an important role in tumor initiation, progression, and
invasion. Our previous research has already shown that large-scale tumor-associated …

Purpose: Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy with few
therapies; however, patients with locoregional disease have variable outcomes. The Cancer …